CHEK2 and cancer: Oncogenic activation and ensuing RS commonly evoke oncogene-induced senescence (OIS) or death of the incipient cancer cells, at the same time providing a context with selective pressure for outgrowth of cancer cells with defective DDR checkpoints, such as those with mutations in the ATM-Chk2-p53 axis [20].